Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000899923-26-000032
Filing Date
2026-04-14
Accepted
2026-04-14 17:02:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-2025proxyadditiona.htm DEFA14A 8981
2 capture5a.jpg GRAPHIC 59935
3 capture6a.jpg GRAPHIC 146039
4 capture7a.jpg GRAPHIC 38945
5 capture8a.jpg GRAPHIC 77629
  Complete submission text file 0000899923-26-000032.txt   451906
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 26861524
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)